[{"NetIncomeLoss_1_Q1_USD":653138000.0,"MarketableSecuritiesCurrent_0_Q1_USD":619638000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":81800000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1532037000.0,"EquitySecuritiesFvNiUnrealizedGain_1_Q1_USD":92059000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":83221000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":185700000.0,"InterestPaidNet_1_Q1_USD":14534000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-33302000.0,"EquitySecuritiesFvNiCost_0_Q1_USD":51427000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":31251000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-74309000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1_Q1_USD":-9300000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":1430000.0,"AssetsCurrent_0_Q1_USD":8539307000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-2332000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":121455000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":192077000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":530330000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q1_USD":33966000.0,"ContractWithCustomerLiability_0_Q1_USD":181200000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":192329000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":83923000.0,"EquitySecuritiesFvNiUnrealizedLoss_1_Q1_USD":0.0,"IncomeTaxesPaidNet_1_Q1_USD":10691000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":102140000.0,"EquitySecuritiesFvNi_0_Q1_USD":143486000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":15559000.0,"Cash_0_Q1_USD":2400000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":118072000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-4030000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-218000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-52295000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":12233000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":261916000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-52653000.0,"AccountsReceivableNetCurrent_0_Q1_USD":977551000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":167822000.0,"CommonStockValue_0_Q1_USD":2588000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":115174000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":8022000.0,"Liabilities_0_Q1_USD":3134805000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":28834000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.2,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-518654000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-3900000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"CostsAndExpenses_1_Q1_USD":836479000.0,"IncreaseDecreaseInInventories_1_Q1_USD":22785000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":688316000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-10644000.0,"OtherAssetsNoncurrent_0_Q1_USD":49262000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":6304330000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":368467000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":7499161000.0,"IncreaseDecreaseInOtherDeferredLiability_1_Q1_USD":57043000.0,"CommonStockSharesIssued_0_Q1_shares":258829000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":170721000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":4366455000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":1511807000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":324062000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":98373000.0,"CommonStockSharesOutstanding_0_Q1_shares":258829000.0,"EarningsPerShareDiluted_1_Q1_USD":2.49,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":35178000.0,"Goodwill_0_Q1_USD":1002158000.0,"InterestIncomeExpenseNet_1_Q1_USD":-15678000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":102140000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":117037000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":921055000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":8277000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":44921000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":259369000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":4358433000.0,"LiabilitiesCurrent_0_Q1_USD":1944050000.0,"AccountsPayableCurrent_0_Q1_USD":127839000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":6312907000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":338925000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":400000000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":185700000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":1480000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_1_Q1_USD":0.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q1_USD":15178000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":70926000.0,"StockholdersEquity_0_Q1_USD":8980254000.0,"OtherLiabilitiesCurrent_0_Q1_USD":284174000.0,"Assets_0_Q1_USD":12115059000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-52295000.0,"ShareBasedCompensation_1_Q1_USD":115174000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":322319000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":1863000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q1_USD":815890000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"InvestmentIncomeInterestAndDividend_1_Q1_USD":1465000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q1_USD":986123000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":13319000.0,"IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_1_Q1_shares":8000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1724305000.0,"OperatingIncomeLoss_1_Q1_USD":887826000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":820960000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":424952000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_1_Q1_USD":22231000.0,"InventoryNet_0_Q1_USD":298863000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":424952000.0,"PreferredStockValue_0_Q1_USD":0.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1_Q1_USD":-12947000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":12115059000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":115174000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":152983000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":106258000.0,"EarningsPerShareBasic_1_Q1_USD":2.52,"ResearchAndDevelopmentExpense_1_Q1_USD":455973000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210430"}]